A study to determine the reliability of a top mount actuation indicator when used with levalbuterol tartrate [levosalbutamol] HFA [hydrofluoroalkane] MDI [metered-dose inhaler] in adult and pediatric subjects with asthma or chronic obstructive pulmonary disease

Trial Profile

A study to determine the reliability of a top mount actuation indicator when used with levalbuterol tartrate [levosalbutamol] HFA [hydrofluoroalkane] MDI [metered-dose inhaler] in adult and pediatric subjects with asthma or chronic obstructive pulmonary disease

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Feb 2012

At a glance

  • Drugs Levosalbutamol (Primary)
  • Indications Asthma; Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Sponsors Sunovion Pharmaceuticals
  • Most Recent Events

    • 22 Jan 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top